Brentville et al. demonstrated that transduced tumor cells can present a citrullinated vimentin peptide on HLA-DR4 molecules, and that differential recognition by CD4 T cells occurs compared to the WT counterpart peptide [136]. Here, CD4 is linked to neoplasm.